{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:43:54Z","timestamp":1793763834083,"version":"4.6.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR 152"],"award-info":[{"award-number":["TRR 152"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejphar.2021.174702","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T11:29:56Z","timestamp":1639481396000},"page":"174702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Valdecoxib blocks rat TRPV2 channels"],"prefix":"10.1016","volume":"915","author":[{"given":"Yannik","family":"Bluhm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5536-0797","authenticated-orcid":false,"given":"Rick","family":"Raudszus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5516-7922","authenticated-orcid":false,"given":"Nicole","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1306-8824","authenticated-orcid":false,"given":"Kerstin","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.174702_bib1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/18906","article-title":"A capsaicin-receptor homologue with a high threshold for noxious heat","volume":"398","author":"Caterina","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2021.174702_bib3","unstructured":"Colton CK, Zhu MX. 2-Aminoethoxydiphenyl borate as a common activator of TRPV1, TRPV2, and TRPV3 channels. Handb. Exp. Pharmacol. (10.1007\/978-3-540-34891-7_10)."},{"key":"10.1016\/j.ejphar.2021.174702_bib4","doi-asserted-by":"crossref","first-page":"33459","DOI":"10.18632\/oncotarget.9663","article-title":"TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer","volume":"9","author":"Elbaz","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2021.174702_bib5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fimmu.2012.00150","article-title":"The role of TRP proteins in mast cells","volume":"3","author":"Freichel","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2021.174702_bib6","doi-asserted-by":"crossref","first-page":"24359","DOI":"10.1073\/pnas.1904332116","article-title":"Oxidation of methionine residues activates the high-threshold heat-sensitive ion channel TRPV2","volume":"116","author":"Fricke","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2021.174702_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13104-015-1023-1","article-title":"Evidence of more ion channels inhibited by celecoxib: KV1.3 and L-type Ca(2+) channels","volume":"8","author":"Frolov","year":"2015","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.ejphar.2021.174702_bib8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/sji.12206","article-title":"TRPV2 in the development of experimental colitis","volume":"80","author":"Issa","year":"2014","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ejphar.2021.174702_bib9","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1083\/jcb.200301101","article-title":"A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel","volume":"161","author":"Iwata","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejphar.2021.174702_bib10","doi-asserted-by":"crossref","first-page":"14042","DOI":"10.18632\/oncotarget.24449","article-title":"Novel inhibitor candidates of TRPV2 prevent damage of dystrophic myocytes and ameliorate against dilated cardiomyopathy in a hamster model","volume":"9","author":"Iwata","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2021.174702_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/11086","article-title":"Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I","volume":"1","author":"Kanzaki","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2021.174702_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/md15040087","article-title":"Marine cyclic guanidine alkaloids monanchomycalin B and urupocidin A act as inhibitors of TRPV1, TRPV2 and TRPV3, but not TRPA1 receptors","volume":"15","author":"Korolkova","year":"2017","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejphar.2021.174702_bib13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1083\/jcb.200203048","article-title":"Ca2+-controlled competitive diacylglycerol binding of protein kinase C isoenzymes in living cells","volume":"159","author":"Lenz","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejphar.2021.174702_bib14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ni.1842","article-title":"TRPV2 has a pivotal role in macrophage particle binding and phagocytosis","volume":"11","author":"Link","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2021.174702_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/carcin\/bgs328","article-title":"Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents","volume":"34","author":"Nabissi","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejphar.2021.174702_bib16","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/jcp.20883","article-title":"Chemotactic peptide fMetLeuPhe induces translocation of the TRPV2 channel in macrophages","volume":"210","author":"Nagasawa","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2021.174702_bib17","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3389\/fphar.2019.01198","article-title":"2-APB and CBD-mediated targeting of charged cytotoxic compounds into tumor cells suggests the involvement of TRPV2 channels","volume":"10","author":"Neumann-Raizel","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174702_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0143-4160(97)90107-X","article-title":"Inhibition of proliferation of MCF-7 breast cancer cells by a blocker of Ca(2+)-permeable channel","volume":"22","author":"Nie","year":"1997","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ejphar.2021.174702_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1476-5381.2012.01987.x","article-title":"Positive allosteric modulation by ivermectin of human but not murine P2X7 receptors","volume":"167","author":"N\u00f6renberg","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174702_bib20","doi-asserted-by":"crossref","first-page":"11425","DOI":"10.1523\/JNEUROSCI.1384-09.2011","article-title":"TRP vanilloid 2 knock-out mice are susceptible to perinatal lethality but display normal thermal and mechanical nociception","volume":"31","author":"Park","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174702_bib21","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1111\/febs.12302","article-title":"What do we know about the transient receptor potential vanilloid 2 (TRPV2) ion channel?","volume":"280","author":"Per\u00e1lvarez-Mar\u00edn","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.ejphar.2021.174702_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1748-1716.2011.02338.x","article-title":"Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation","volume":"204","author":"Petrocellis","year":"2012","journal-title":"Acta Physiol."},{"key":"10.1016\/j.ejphar.2021.174702_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbamem.2014.09.008","article-title":"Mechanosensitive Ca2\u207a-permeable channels in human leukemic cells: pharmacological and molecular evidence for TRPV2","volume":"1848","author":"Pottosin","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2021.174702_bib24","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1523\/JNEUROSCI.0504-08.2008","article-title":"TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons","volume":"28","author":"Qin","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174702_bib25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41374-019-0333-7","article-title":"The TRPV2 cation channels: from urothelial cancer invasiveness to glioblastoma multiforme interactome signature","volume":"100","author":"Santoni","year":"2020","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ejphar.2021.174702_bib26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fimmu.2013.00034","article-title":"The role of transient receptor potential vanilloid type-2 ion channels in innate and adaptive immune responses","volume":"4","author":"Santoni","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2021.174702_bib27","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1523\/JNEUROSCI.5830-09.2010","article-title":"TRPV2 enhances axon outgrowth through its activation by membrane stretch in developing sensory and motor neurons","volume":"30","author":"Shibasaki","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174702_bib28","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/s41598-018-37469-8","article-title":"Evaluation of cationic channel TRPV2 as a novel biomarker and therapeutic target in Leukemia-Implications concerning the resolution of pulmonary inflammation","volume":"9","author":"Siveen","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.174702_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171366","article-title":"Analysis of TRPV channel activation by stimulation of FC\u03b5RI and MRGPR receptors in mouse peritoneal mast cells","volume":"12","author":"Sol\u00eds-L\u00f3pez","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2021.174702_bib30","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1111\/bph.13893","article-title":"COX-2-selective inhibitors celecoxib and deracoxib modulate transient receptor potential vanilloid 3 channels","volume":"174","author":"Spyra","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174702_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1084\/jem.20032082","article-title":"A TRPV2-PKA signaling module for transduction of physical stimuli in mast cells","volume":"200","author":"Stokes","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2021.174702_bib32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ceca.2012.01.001","article-title":"Novel pharmacological TRPC inhibitors block hypoxia-induced vasoconstriction","volume":"51","author":"Urban","year":"2012","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ejphar.2021.174702_bib33","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200118","article-title":"TRPV2 interacts with actin and reorganizes submembranous actin cytoskeleton","volume":"40","author":"Yadav","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ejphar.2021.174702_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.33549\/physiolres.932053","article-title":"Mast-cell degranulation induced by physical stimuli involves the activation of transient-receptor-potential channel TRPV2","volume":"61","author":"Zhang","year":"2012","journal-title":"Physiol. Res."},{"key":"10.1016\/j.ejphar.2021.174702_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12032-014-0017-5","article-title":"Overexpression of transient receptor potential vanilloid 2 is associated with poor prognosis in patients with esophageal squamous cell carcinoma","volume":"31","author":"Zhou","year":"2014","journal-title":"Med. Oncol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992100858X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992100858X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:56:56Z","timestamp":1757977016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992100858X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":34,"alternative-id":["S001429992100858X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174702","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valdecoxib blocks rat TRPV2 channels","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174702"}}